Teodora Kuzmanovic

1.6k total citations
30 papers, 295 citations indexed

About

Teodora Kuzmanovic is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Teodora Kuzmanovic has authored 30 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 12 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Teodora Kuzmanovic's work include Acute Myeloid Leukemia Research (26 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Cancer Genomics and Diagnostics (8 papers). Teodora Kuzmanovic is often cited by papers focused on Acute Myeloid Leukemia Research (26 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers) and Cancer Genomics and Diagnostics (8 papers). Teodora Kuzmanovic collaborates with scholars based in United States, Germany and Japan. Teodora Kuzmanovic's co-authors include Saurabh Chattopadhyay, Ganes C. Sen, Jaime L. Wetzel, Ying Zhang, Jaroslaw P. Maciejewski, Ying Zhang, G. Mani Subramanian, Manoj Veleeparambil, Ritu Chakravarti and Mikkael A. Sekeres and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Immunity.

In The Last Decade

Teodora Kuzmanovic

30 papers receiving 294 citations

Peers

Teodora Kuzmanovic
Comparison fields: 5 of 59
  • Molecular Biology 133
  • Immunology 129
  • Hematology 86
  • Oncology 45
  • Epidemiology 44
Carla Pereira Canada
Uma Mudunuru United States
Yvonne Suessmuth United States
Maiken L. Henriksen Denmark
Anne Slomp Netherlands
Shun Iida Japan
Xufeng Luo China
Erica Giuliani Italy
Anja Stirnweiß Australia
Paola Terranova Italy
Carla Pereira Canada View profile →
Citations per field, relative to Teodora Kuzmanovic
Teodora Kuzmanovic · 1×
Citations per year, relative to Teodora Kuzmanovic
Teodora Kuzmanovic · 1×

Countries citing papers authored by Teodora Kuzmanovic

Since Specialization
Citations

This map shows the geographic impact of Teodora Kuzmanovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teodora Kuzmanovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teodora Kuzmanovic more than expected).

Fields of papers citing papers by Teodora Kuzmanovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teodora Kuzmanovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teodora Kuzmanovic. The network helps show where Teodora Kuzmanovic may publish in the future.

Co-authorship network of co-authors of Teodora Kuzmanovic

This figure shows the co-authorship network connecting the top 25 collaborators of Teodora Kuzmanovic. A scholar is included among the top collaborators of Teodora Kuzmanovic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teodora Kuzmanovic. Teodora Kuzmanovic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Clonal hematopoiesis–derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders
2024 ·Leukemia ·Hussein Awada, Carmelo Gurnari, Valeria Visconte, Arda Durmaz, Teodora Kuzmanovic, Hassan Awada, Zheng Jin Tu, James R. Cook, Brian J. Bolwell, Ronald Sobecks, Matt Kalaycio, David Bosler, Jaroslaw P. Maciejewski
5
2
A machine learning model of response to hypomethylating agents in myelodysplastic syndromes
2022 ·iScience ·Nathan Radakovich, David A. Sallman, Rena Buckstein, Andrew M. Brunner, Amy E. DeZern, (unknown), Rami S. Komrokji, (unknown), Jacob Shreve, (unknown), (unknown), Alexandre Mamedov, Mohammed Siddiqui, Yihong Guan, Teodora Kuzmanovic, Metis Hasipek, Babal K. Jha, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Aziz Nazha
10
3
AML-156: The Clinical Implications and Outcomes of RAS Mutatome in Core-Binding Factor Acute Myeloid Leukemia
2020 ·Clinical Lymphoma Myeloma & Leukemia ·Hassan Awada, Carmelo Gurnari, Manja Meggendorfer, Arda Durmaz, Teodora Kuzmanovic, Cassandra M Kerr, Hetty E. Carraway, Aziz Nazha, Torsten Haferlach, Mikkael A. Sekeres, Valeria Visconte, Jaroslaw P. Maciejewski
1
4
A Personalized Prediction Model to Risk Stratify Patients with Acute Myeloid Leukemia (AML) Using Artificial Intelligence
2019 ·Blood ·Jacob Shreve, Manja Meggendorfer, Hassan Awada, Sudipto Mukherjee, Wencke Walter, Stephan Hütter, (unknown), (unknown), Nathan Radakovich, Yasunobu Nagata, (unknown), Vera Ademà, Cassandra M Kerr, Bhumika J. Patel, Teodora Kuzmanovic, Jaroslaw P. Maciejewski, Claudia Haferlach, Mikkael A. Sekeres, Torsten Haferlach, Aziz Nazha
15
5
Predicting Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS) Using Artificial Intelligence (AI)
2019 ·Blood ·Nathan Radakovich, Mikkael A. Sekeres, (unknown), Sudipto Mukherjee, Jacob Shreve, (unknown), Rachel Shirley, Vera Ademà, Hassan Awada, Anjali S. Advani, Cassandra M Kerr, Yasunobu Nagata, Yihong Guan, Teodora Kuzmanovic, Metis Hasipek, Babal K. Jha, Jaroslaw P. Maciejewski, Aziz Nazha
4
6
Impact and Outcomes of RAS gene Mutations in Core Binding Factor Acute Myeloid Leukemia
2019 ·Blood ·Hassan Awada, Ashwin Kishtagari, Teodora Kuzmanovic, Jibran Durrani, Cassandra M Kerr, Manja Meggendorfer, Anjali S. Advani, Aziz Nazha, Hetty E. Carraway, Torsten Haferlach, Mikkael A. Sekeres, Valeria Visconte, Jaroslaw P. Maciejewski
5
7
Distinct clinical and biological implications of CUX1 in myeloid neoplasms
2019 ·Blood Advances ·Mai Aly, Zubaidah M. Ramdzan, Yasunobu Nagata, Suresh Kumar Balasubramanian, Naoko Hosono, Hideki Makishima, Valeria Visconte, Teodora Kuzmanovic, Vera Ademà, Aziz Nazha, Bartlomiej Przychodzen, Cassandra M Kerr, Mikkael A. Sekeres, Mohamed E. Abazeed, Alain Nepveu, Jaroslaw P. Maciejewski
26
8
Extended Experience with a Very Low Dose, Metronomic, Subcutaneous Decitabine Regimen Intended to Deplete DNMT1 without Cytotoxicity
2019 ·Blood ·Ashwin Kishtagari, Hassan Awada, Reda Z. Mahfouz, Teodora Kuzmanovic, Jibran Durrani, Cassandra M Kerr, Bhumika J. Patel, Valeria Visconte, Tomas Radivoyevitch, Alan Lichtin, Hetty E. Carraway, Jaroslaw P. Maciejewski, (unknown)
2
9
RORA Is a Potential Prognostic Biomarker and Therapeutic Target for Patients with Acute Myeloid Leukemia
2019 ·Blood ·(unknown), Kevin Fung, (unknown), Vera Ademà, Cassandra M Kerr, Sunisa Kongkiatkamon, Hassan Awada, (unknown), Teodora Kuzmanovic, Bhumika J. Patel, Aaron T. Gerds, Sudipto Mukherjee, Aziz Nazha, Hetty E. Carraway, Tomas Radivoyevitch, Jaroslaw P. Maciejewski, Valeria Visconte, Mikkael A. Sekeres, Anjali S. Advani
1
10
A new mechanism of interferon’s antiviral action: Induction of autophagy, essential for paramyxovirus replication, is inhibited by the interferon stimulated gene, TDRD7
2018 ·PLoS Pathogens ·G. Mani Subramanian, Teodora Kuzmanovic, Ying Zhang, (unknown), Manoj Veleeparambil, Ritu Chakravarti, Ganes C. Sen, Saurabh Chattopadhyay
50
11
Somatic Mutations in Therapy-Related Myeloid Neoplasms Are Influenced By Therapeutic Modality and Clonal Hematopoiesis of Indeterminate Potential
2018 ·Blood ·Teodora Kuzmanovic, Bhumika J. Patel, (unknown), Yasunobu Nagata, Hassan Awada, Cassandra M. Hirsch, Bartlomiej Przychodzen, Remco J. Molenaar, Babal K. Jha, Sudipto Mukherjee, Anjali S. Advani, Aziz Nazha, Aaron T. Gerds, Hetty E. Carraway, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Tomas Radivoyevitch
1
12
Mutational Landscape of Therapy-Related Myeloid Neoplasms
2018 ·Clinical Lymphoma Myeloma & Leukemia ·Teodora Kuzmanovic, Tomas Radivoyevitch, (unknown), Bhumika J. Patel, Yasunobu Nagata, Cassandra M. Hirsch, Bartlomiej Przychodzen, Hassan Awada, Sudipto Mukherjee, Anjali S. Advani, Aziz Nazha, Aaron T. Gerds, Hetty E. Carraway, Mikkael A. Sekeres, Jaroslaw P. Maciejewski
1
13
Mutational Signatures Associated with Intensity and Duration of Smoking in Myelodysplastic Syndromes (MDS)
2017 ·Blood ·Yazan F. Madanat, Tomas Radivoyevitch, Aziz Nazha, Yazeed Sawalha, (unknown), Nour Abuhadra, Teodora Kuzmanovic, Bartlomiej Przychodzen, Cassandra M. Hirsch, Bhumika J. Patel, David J. Seastone, (unknown), Sudipto Mukherjee, Anjali S. Advani, Hetty E. Carraway, Aaron T. Gerds, Jaroslaw P. Maciejewski, Mikkael A. Sekeres
1
14
Model Heterogeneity in Predicting Outcomes of Patients with Myelodysplastic Syndromes (MDS)
2017 ·Blood ·(unknown), Yazan F. Madanat, Sudipto Mukherjee, Cassandra M. Hirsch, Aaron T. Gerds, Nour Abuhadra, (unknown), Hassan Awada, (unknown), Abhinav Goyal, Anjali S. Advani, Teodora Kuzmanovic, Bartlomiej Przychodzen, Hetty E. Carraway, Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Aziz Nazha
2
15
Germline SAMD9 and SAMD9L Alterations in Adult Myelodysplastic Syndromes
2017 ·Blood ·Yasunobu Nagata, Bartlomiej Przychodzen, Cassandra M. Hirsch, Hideki Makishima, (unknown), Babal K. Jha, Teodora Kuzmanovic, Tomas Radivoyevitch, Vera Ademà, Kenichi Yoshida, (unknown), Françesc Solé, Thomas LaFramboise, Rabi Hanna, Mikkael A. Sekeres, Seishi Ogawa, Marcin W. Włodarski, Jörg Cammenga, Jaroslaw P. Maciejewski
3
16
Deletion of Ptpn1 induces myeloproliferative neoplasm
2017 ·Leukemia ·(unknown), Bhumika J. Patel, Teodora Kuzmanovic, Hideki Makishima, Yue Yang, Bartlomiej Przychodzen, R. Hutchison, Kendra K. Bence, Jaroslaw P. Maciejewski, Golam Mohi
7
17
Ubiquitination of the Transcription Factor IRF-3 Activates RIPA, the Apoptotic Pathway that Protects Mice from Viral Pathogenesis
2016 ·Immunity ·Saurabh Chattopadhyay, Teodora Kuzmanovic, Ying Zhang, Jaime L. Wetzel, Ganes C. Sen
119
18
U2AF1 Mutations in S34 and Q157 Create Distinct Molecular and Clinical Contexts
2016 ·Blood ·Vera Ademà, Cassandra M. Hirsch, Bartlomiej Przychodzen, Aziz Nazha, Teodora Kuzmanovic, Eiju Negoro, Dewen You, Hideki Makishima, Michael J. Clemente, Hetty E. Carraway, Mikkael A. Sekeres, Valeria Visconte, Jaroslaw P. Maciejewski
4
19
Impact of Erythropoietic Stimulating Agents on Mutational Composition in Patients with Low-Risk Myelodysplastic Syndromes
2016 ·Blood ·Bhumika J. Patel, Caner Saygin, Bartlomiej Przychodzen, Teodora Kuzmanovic, Cassandra M. Hirsch, Michael J. Clemente, Swapna Thota, Aziz Nazha, (unknown), Jaroslaw P. Maciejewski, Hetty E. Carraway
1
20
Clonal Events of Aplastic Anemia Related to the Evolution to Myelodysplastic Syndrome
2016 ·Blood ·Eiju Negoro, Michael J. Clemente, Naoko Hosono, Aziz Nazha, Wenyi Shen, Yasunobu Nagata, Cassandra M. Hirsch, Bartlomiej Przychodzen, Reda Z. Mahfouz, Teodora Kuzmanovic, Hideki Makishima, Mikkael A. Sekeres, Jaroslaw P. Maciejewski
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla Pereira Breakdown of academic impact, for papers by Uma Mudunuru Breakdown of academic impact, for papers by Yvonne Suessmuth Breakdown of academic impact, for papers by Maiken L. Henriksen Breakdown of academic impact, for papers by Anne Slomp Breakdown of academic impact, for papers by Shun Iida Breakdown of academic impact, for papers by Xufeng Luo Breakdown of academic impact, for papers by Erica Giuliani Breakdown of academic impact, for papers by Anja Stirnweiß Breakdown of academic impact, for papers by Paola Terranova
Rankless by CCL
2026